Cullinan Therapeutics Inc.
CGEM | NASDAQ
$21.35
+$0.27 (+1.28%)
At close: Sep 21, 2026, 4:00 PM ET
$21.46
+$0.11 (+0.52%)
Pre-market:
Sep 22, 2026, 8:44 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -2.78 | -3.92 | -2.76 | 4.29 | -10.43 | -25.13 |
PEG Ratio | -0.14 | 0.25 | 0.01 | -0.02 | -0.43 | 0.27 |
PS Ratio | n/a | n/a | n/a | n/a | 36.08 | n/a |
PB Ratio | 1.50 | 1.11 | 0.93 | 0.89 | 1.61 | 6.54 |
P/FCF Ratio | -3.48 | -4.51 | -3.15 | -3.73 | -15.52 | -43.70 |
P/OCF Ratio | -3.48 | -4.51 | -3.15 | -3.76 | -15.74 | -43.72 |
OCF/S Ratio | n/a | n/a | n/a | n/a | -229.28 | n/a |
Debt / Equity Ratio | 0.01 | 0 | 0.01 | 0.01 | n/a | n/a |
Quick Ratio | 10.25 | 13.53 | 17.07 | 21.09 | 25.25 | 14.82 |
Current Ratio | 10.25 | 13.53 | 17.07 | 21.09 | 25.25 | 14.82 |
Asset Turnover | n/a | n/a | n/a | n/a | 0.04 | n/a |
Interest Coverage | n/a | n/a | n/a | n/a | n/a | n/a |
Return on Equity | -53.80% | -28.35% | -33.76% | 20.79% | -15.43% | -26.03% |
Return on Assets | -49.04% | -26.92% | -31.63% | 19.82% | -15% | -24.13% |
Return on Invested Capital | -58.74% | -33.24% | -38.28% | 19.32% | -15.97% | -30.11% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | 100% | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | -346.14% | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | -356.25% | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | -358.73% | n/a |
FCF Margin | n/a | n/a | n/a | n/a | -232.39% | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | -355.97% | n/a |
Add to Watchlist
Select watchlists to add or remove CGEM